Skip to main content
SpringerLink
Log in

Late stent thrombosis, endothelialisation and drug-eluting stents

  • Interuniversity Cardiology Institute of the Netherlands
  • Published:
Netherlands Heart Journal Aims and scope Submit manuscript

Abstract

Drug-eluting stents (DES) significantly reduce the risk of restenosis after percutaneous coronary revascularisation, but an increased risk of late stent thrombosis (LST) has been put forward as a major safety concern. Meta-analysis of clinical trials, however, does not support this caveat. Even so, many interventional cardiologists think that LST is associated with DES and related to delayed endothelialisation. This hypothesis is based on autopsy studies and clinical intracoronary angioscopy. In autopsy studies, differences between endothelialisation of DES and baremetal stents (BMS) have been reported. Most preclinical studies, however, have failed to show any significant differences in endothelialisation between DES and BMS. Our own studies, using the porcine coronary artery model, also suggest that DES show no differences in re-endothelialisation. However, DES do delay vascular healing and induce endothelial dysfunction. This paper will review clinical and animal studies which consider re-endothelialisation and LST. (Neth Heart J 2009;17:177–81.)

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773–80.

    Google Scholar 

  2. Park SJ, Shim WH, Ho DS, Raizner AE, Park SW, Hong MK, et al. A paclitaxel-eluting stent for the prevention of coronary stenosis. N Engl J Med 2003;348:1537–45.

    Google Scholar 

  3. Collected_DES papers. Sections “perspectives”, “original articles” and “editorial”. N Engl J Med 2007;356:981–1039,1059–60.

    Google Scholar 

  4. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 2007;115:2435–41.

    Google Scholar 

  5. Kotani J, Awata M, Nanto S, Uematsu M, Oshima F, Minamiguchi H. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol 2006;47:2108–11.

    Google Scholar 

  6. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins, KD, Morice MC, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007;356:998–1008.

    Google Scholar 

  7. Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A, et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 2007;370:937–48.

    Google Scholar 

  8. Garg P, Cohen DJ, Gaziano T, Mauri L. Balancing the risks of restenosis and stent thrombosis in bare-metal versus drug-eluting stents: results of a decision analytic model. J Am Coll Cardiol 2008;51:1844–53.

    Google Scholar 

  9. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large twoinstitutional cohort study. Lancet 2007;369:667–78.

    Google Scholar 

  10. Wenaweser P, Daemen J, Zwahlen M, van Domburg R, Jüni P, Vaina S, et al. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. J Am Coll Cardiol 2008;52:1134–40.

    Google Scholar 

  11. Mauri L, Hsieh WH, Massaro JM, Ho KK, D’Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007;356:1020–9.

    Google Scholar 

  12. Awata M, Kotani J, Uematsu M, Morozumi T, Watanabe T, Onishi T, et al. Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents. Circulation 2007;116:910–6.

    Google Scholar 

  13. Awata M, Nanto S, Uematsu M, Morozumi T, Watanabe T, Onishi T, et al. Angioscopic comparison of neointimal coverage between zotarolimus and sirolimus-eluting stents. J Am Coll Cardiol 2008;52:787–92.

    Google Scholar 

  14. van Beusekom HM, Whelan DM, Hofma SH, Krabbendam SC, van Hinsbergh VW, Verdouw PD, et al. Long-term endothelial dysfunction is more pronounced after stenting than after balloon angioplasty in porcine coronary arteries. J Am Coll Cardiol 1998;32:1109–17.

    Google Scholar 

  15. Whelan DM, van der Giessen WJ, Krabbendam SC, van Vliet EA, Verdouw PD, Serruys PW, et al. Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries. Heart 2000;83:338–45

    Google Scholar 

  16. Farb A, Burke AP, Kolodgie FD, Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 2003;108: 1701–6.

    Google Scholar 

  17. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193–202.

    Google Scholar 

  18. van Beusekom HM, Saia F, Zindler JD, Lemos PA, Swager-Ten Hoor SL, van Leeuwen MA, et al. Drug-eluting stents show delayed healing: paclitaxel more pronounced than sirolimus. Eur Heart J 2007;28:974–9.

  19. Takase B, Hamabe A, Satomura K, Akima T, Uehata A, Matsui T, et al. Comparable prognostic value of vasodilator response to acetylcholine in brachial and coronary arteries for predicting long-term cardiovascular events in suspected coronary artery disease. Circ J 2006;70:49–56.

    Google Scholar 

  20. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000;101:948–54.

    Google Scholar 

  21. Hofma SH, van der Giessen WJ, van Dalen BM, Lemos PA, McFadden EP, Sianos G, et al. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J 2006;27:166–70.

    Google Scholar 

  22. Togni M, Windecker S, Cocchia R, Wenaweser P, Cook S, Billinger M, et al. Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol 2005;46:231–6.

    Google Scholar 

  23. Togni M, Räber L, Cocchia R, Wenaweser P, Cook S, Windecker S, et al. Local vascular dysfunction after coronary paclitaxel-eluting stent implantation. Int J Cardiol 2007;120:212–20.

    Google Scholar 

  24. Shin DI, Kim PJ, Seung KB, Kim DB, Kim MJ, Chang K, et al. Drugeluting stent implantation could be associated with long-term coronary endothelial dysfunction: comparison between sirolimus-eluting stent and paclitaxel-eluting stent. Int Heart J 2007;48:553–67.

    Google Scholar 

  25. Sorop O, Batenburg WW, Koopmans S-J, Dekker R, Duncker D, Danser A, et al. Taxus but not Cypher drug eluting stents induce endothelial dysfunction in the distal coronary microvasculature. Circulation 2007;116:II_293.

    Google Scholar 

  26. Li J, Jabara R, Pendyala L, Otsuka Y, Shinke T, Hou D, et al. Abnormal vasomotor function of porcine coronary arteries distal to sirolimus-eluting stents. J Am Coll Cardiol Intv 2008;1:279–85.

    Google Scholar 

  27. Onuma Y, van Beusekom HM, Sorop O, van der Giessen WJ. The paradigm of endothelium and stent thrombosis in DES. EuroIntervention 2008;4: 17–21.

    Google Scholar 

  28. Suzuki T, Kopia G, Hayashi S, Bailey LR, Llanos G, Wilensky R, et al. Stentbased delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 2001;104:1188–93.

    Google Scholar 

  29. Klugherz BD, Llanos G, Lieuallen W, Kopia GA, Papandreou G, Narayan P et al. Twenty-eight-day efficacy and phamacokinetics of the sirolimuseluting stent. Coron Artery Dis 2002;13:183–8.

    Google Scholar 

  30. Finn AV, Kolodgie FD, Harnek J, Guerrero LJ, Acampado E, Tefera K, et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 2005;112:270–8.

    Google Scholar 

  31. Joner M, Nakazawa G, Finn AV, Quee SC, Coleman L, Acampado E, et al. Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol 2008;52:333–42.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. www.bsl.nl/shop/

    G. Ertaş

Authors
  1. G. Ertaş
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. M. van Beusekom
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W. J. van der Giessen
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Department of Cardiology, Thoraxcenter, Erasmus MC Rotterdam, the Netherlands and Department of Cardiology, Kocaeli University, Kocaeli, Turkey

Department of Cardiology, Thoraxcenter, Erasmus MC Rotterdam, the Netherlands

Department of Cardiology, Thoraxcenter, Erasmus MC Rotterdam and Interuniversity Cardiology Institute of the Netherlands, ICIN-KNAW, Utrecht, the Netherlands

W.J. van der Giessen Department of Cardiology, Thoraxcenter, Ee2393, Erasmus MC Rotterdam, PO Box 2040, 3000 CA Rotterdam, the Netherlands

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ertaş, G., van Beusekom, H.M. & van der Giessen, W.J. Late stent thrombosis, endothelialisation and drug-eluting stents. NHJL 17, 177–180 (2009). https://doi.org/10.1007/BF03086242

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03086242

Search

Navigation